ARCHIVES

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

This article is from The Cancer Letter archive.

Vol. 33 No. 17 | May 4, 2007

Download PDF Visit The Full Archive

Related Articles

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Funding Opportunities

October 11, 2002

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

In Brief: NIH Intramural Research Said Needing Better Peer Review, Change In Selecting Counselors

April 23, 1976

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004